Solubility based Biowaiver [Dissolution / BCS / IVIVC]

posted by Amalia – Greece, 2018-10-02 06:59 (847 d 05:48 ago) – Posting: # 19360
Views: 4,258

Dear Obinoscopy,

what I guess I should have clarified is that the reason we are trying to use this justification is because the lower strength is not proportional in terms of excipients.

» The advise was given by an "external clinical expert".

I presume this is why we were advised to follow the solubility path for a biowaiver? That is why we are wondering whether we should perform the solubility tests at the API or the final formulation.
What do you think?

Kind Regards,

Amalia

Complete thread:

Activity
 Admin contact
21,314 posts in 4,446 threads, 1,489 registered users;
online 8 (0 registered, 8 guests [including 7 identified bots]).
Forum time: Tuesday 12:47 UTC (Europe/Vienna)

Any one who considers arithmetical methods
of producing random digits is, of course,
in a state of sin.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5